Global Bio-chem Technology Group Company Limited

Symbol: 0809.HK

HKSE

0.102

HKD

Market price today

  • 0.2024

    P/E Ratio

  • 0.0037

    PEG Ratio

  • 908.56M

    MRK Cap

  • 0.00%

    DIV Yield

Global Bio-chem Technology Group Company Limited (0809-HK) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.03%

Operating Profit Margin

-0.24%

Net Profit Margin

3.07%

Return on Assets

0.81%

Return on Equity

-0.75%

Return on Capital Employed

0.10%

Company general description and statistics

Sector: Consumer Defensive
Industry: Packaged Foods
CEO:Mr. Cheng Wang
Full-time employees:2154
City:Hung Hom
Address:Tower A, Cheung Kei Center
IPO:2001-03-16
CIK:

Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, rest of Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, including corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meal, feed pellets, and corn germ cake. It also provides downstream corn based biochemical products, such as amino acids comprising lysine, protein lysine, threonine, and glutamic acid; corn sweeteners, which include high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose; modified starches; and chemicals comprising ethylene, propylene, and butylene glycols, as well as resins. In addition, the company offers anti-freeze products, hydrogen, and ammonia. Its products are used in various applications, such as feed production, food and beverage, cosmetics, textiles, pharmaceuticals, chemical industries, etc. The company was founded in 1994 and is headquartered in Hung Hom, Hong Kong.

General Outlook

When we look at how much money they make before expenses, they keep 0.032% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.238%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 3.075%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.811% return, is a testament to Global Bio-chem Technology Group Company Limited's adeptness in optimizing resource deployment. Global Bio-chem Technology Group Company Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.750%. Furthermore, the proficiency of Global Bio-chem Technology Group Company Limited in capital utilization is underscored by a remarkable 0.102% return on capital employed.

Stock Prices

Global Bio-chem Technology Group Company Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.112, while its low point bottomed out at $0.097. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Global Bio-chem Technology Group Company Limited's stock market.

Liquidity Ratios

Analyzing 0809.HK liquidity ratios reveals its financial health of the firm. The current ratio of 11.55% gauges short-term asset coverage for liabilities. The quick ratio (8.48%) assesses immediate liquidity, while the cash ratio (1.05%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio11.55%
Quick Ratio8.48%
Cash Ratio1.05%

Profitability Ratios

0809.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 269.37% underscores its earnings before tax deductions. The effective tax rate stands at -1.14%, revealing its tax efficiency. The net income per EBT, 114.15%, and the EBT per EBIT, -1133.93%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -23.76%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin269.37%
Effective Tax Rate-1.14%
Net Income per EBT114.15%
EBT per EBIT-1133.93%
EBIT per Revenue-23.76%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.12, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding8
Days of Inventory Outstanding41
Operating Cycle145.88
Days of Payables Outstanding248
Cash Conversion Cycle-102
Receivables Turnover3.47
Payables Turnover1.47
Inventory Turnover8.97
Fixed Asset Turnover0.33
Asset Turnover0.26

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.01, and free cash flow per share, -0.02, depict cash generation on a per-share basis. The cash per share value, 0.04, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.01
Free Cash Flow per Share-0.02
Cash per Share0.04
Operating Cash Flow Sales Ratio-0.08
Free Cash Flow to Operating Cash Flow Ratio1.42
Cash Flow Coverage Ratio-0.02
Short Term Coverage Ratio-0.02
Capital Expenditure Coverage Ratio-2.37
Dividend Paid and Capex Coverage Ratio-2.37

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 104.62%, highlights its total liabilities relative to assets. With a debt-equity ratio of -1.35, we discern the balance between debt and equity financing. The long-term debt to capitalization, -25.17%, and total debt to capitalization, 385.77%, ratios shed light on its capital structure. An interest coverage of -0.43 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio104.62%
Debt Equity Ratio-1.35
Long Term Debt to Capitalization-25.17%
Total Debt to Capitalization385.77%
Interest Coverage-0.43
Cash Flow to Debt Ratio-0.02
Company Equity Multiplier-1.29

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.10, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.30, reflects the portion of profit attributed to each share. The book value per share, -0.29, represents the net asset value distributed per share, while the tangible book value per share, -0.29, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.10
Net Income Per Share0.30
Book Value Per Share-0.29
Tangible Book Value Per Share-0.29
Shareholders Equity Per Share-0.29
Interest Debt Per Share0.44

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 269.06%, indicates top-line expansion, while the gross profit growth, 26.13%, reveals profitability trends. EBIT growth, 62.54%, and operating income growth, 62.54%, offer insights into operational profitability progression. The net income growth, 378.01%, showcases bottom-line expansion, and the EPS growth, 276.47%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth269.06%
Gross Profit Growth26.13%
EBIT Growth62.54%
Operating Income Growth62.54%
Net Income Growth378.01%
EPS Growth276.47%
EPS Diluted Growth276.47%
Weighted Average Shares Growth58.07%
Weighted Average Shares Diluted Growth58.07%
Operating Cash Flow Growth-17.84%
Free Cash Flow Growth-56.59%
10-Year Revenue Growth per Share-96.71%
5-Year Revenue Growth per Share-88.96%
3-Year Revenue Growth per Share-2.20%
10-Year Operating CF Growth per Share-104.62%
5-Year Operating CF Growth per Share26.92%
3-Year Operating CF Growth per Share-139.32%
10-Year Net Income Growth per Share116.10%
5-Year Net Income Growth per Share257.07%
3-Year Net Income Growth per Share204.91%
10-Year Shareholders Equity Growth per Share-122.00%
5-Year Shareholders Equity Growth per Share46.79%
3-Year Shareholders Equity Growth per Share58.38%
Receivables Growth41.76%
Inventory Growth-31.56%
Asset Growth-10.95%
Book Value per Share Growth66.13%
Debt Growth-33.16%
R&D Expense Growth-37.36%
SGA Expenses Growth-3.39%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 6,853,678,548.3, captures the company's total value, considering both debt and equity. Income quality, -0.03, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.22, gauges operational efficiency, while the research and development to revenue, 0.47%, highlights investment in innovation. The ratio of intangibles to total assets, 0.04%, indicates the value of non-physical assets, and capex to operating cash flow, 42.21%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value6,853,678,548.3
Income Quality-0.03
Sales General and Administrative to Revenue0.22
Research and Development to Revenue0.47%
Intangibles to Total Assets0.04%
Capex to Operating Cash Flow42.21%
Capex to Revenue-3.19%
Capex to Depreciation-18.10%
Graham Number1.39
Return on Tangible Assets81.13%
Graham Net Net-0.61
Working Capital-7,426,073,999
Tangible Asset Value-4,038,953,000
Net Current Asset Value-8,276,473,000
Invested Capital-1
Average Receivables337,622,500
Average Payables1,052,847,000
Average Inventory182,526,000
Days Sales Outstanding105
Days Payables Outstanding248
Days of Inventory On Hand41
ROIC-22.78%
ROE-1.05%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -0.21, and the price to book ratio, -0.21, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.62, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -5.80, and price to operating cash flows, -8.25, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-0.21
Price to Book Ratio-0.21
Price to Sales Ratio0.62
Price Cash Flow Ratio-8.25
Enterprise Value Multiple53.28
Price Fair Value-0.21
Price to Operating Cash Flow Ratio-8.25
Price to Free Cash Flows Ratio-5.80
Price to Tangible Book Ratio-0.37
Enterprise Value to Sales4.99
Enterprise Value Over EBITDA-89.76
EV to Operating Cash Flow-66.08
Earnings Yield283.06%
Free Cash Flow Yield-9.88%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Global Bio-chem Technology Group Company Limited (0809.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 0.202 in 2024.

What is the ticker symbol of Global Bio-chem Technology Group Company Limited stock?

The ticker symbol of Global Bio-chem Technology Group Company Limited stock is 0809.HK.

What is company IPO date?

IPO date of Global Bio-chem Technology Group Company Limited is 2001-03-16.

What is company current share price?

Current share price is 0.102 HKD.

What is stock market cap today?

The market cap of stock today is 908555820.000.

What is PEG ratio in 2024?

The current 0.004 is 0.004 in 2024.

What is the number of employees in 2024?

In 2024 the company has 2154.